DongKook Pharmaceutical Co (XKRX:086450) Purchase Of Investment : ₩-155,376 Mil (TTM As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is DongKook Pharmaceutical Co Purchase Of Investment?

DongKook Pharmaceutical Co's purchase of investment for the three months ended in Dec. 2023 was ₩-24,058 Mil. It means DongKook Pharmaceutical Co spent ₩24,058 Mil on purchasing investments. DongKook Pharmaceutical Co's purchase of investment for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-155,376 Mil.

Compared with last quarter (₩-45,204 Mil in Sep. 2023 ), DongKook Pharmaceutical Co spent less money on purchasing investments in Dec. 2023 (₩-24,058 Mil).

DongKook Pharmaceutical Co Purchase Of Investment Historical Data

The historical data trend for DongKook Pharmaceutical Co's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DongKook Pharmaceutical Co Purchase Of Investment Chart

DongKook Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Purchase Of Investment

Get a 7-Day Free Trial

-107,774.91

-170,233.04

-216,198.49

-260,945.46

-155,376.08

DongKook Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Purchase Of Investment	Get a 7-Day Free Trial															-113,335.12	-65,732.94	-20,381.45	-45,203.86	-24,057.83

DongKook Pharmaceutical Co Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-155,376 Mil.

DongKook Pharmaceutical Co Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of DongKook Pharmaceutical Co's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

DongKook Pharmaceutical Co (XKRX:086450) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DongKook Pharmaceutical Co Ltd (XKRX:086450) » Definitions » Purchase Of Investment

Traded in Other Exchanges

N/A

Address

Dongkook Building 997-8 Daechi 3-dong, Kangnam-gu, Seoul, KOR, 135-502

Website

http://www.dkpharm.co.kr

DongKook Pharmaceutical Co Ltd is a part of the healthcare industry based in Korea. Being a pharmaceutical company, its activities are focused on the research and development of drugs. The company produces superior medicines used favorably by consumers such as Madecassol, which is a drug for wounds and Oramedy, which is a drug for treating stomatitis. It also owns a prefilled syringe system in its second factory, through which it produces various kinds of ultramodern injection agents.

DongKook Pharmaceutical Co (XKRX:086450) Headlines

No Headlines